Department of Orthopaedics, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Department of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Pain Res Manag. 2020 Sep 19;2020:2537075. doi: 10.1155/2020/2537075. eCollection 2020.
Knee osteoarthritis (KOA) is a common degenerative disease associated with joint dysfunction and pain. Ultrasound-guided radiofrequency (RF) may be a promising therapy in the treatment of chronic pain for KOA patients.
To evaluate the efficacy and safety of ultrasound-guided RF treatment for chronic pain in patients with KOA.
A systematic review was conducted, and a meta-analysis was carried out when possible. . We examined the studies evaluating the clinical efficiency of ultrasound-guided RF on chronic pain in KOA population.
A systematic review for the efficacy and safety of ultrasound-guided RF treatment for pain management of KOA patients was carried out in PubMed, EMBASE, Cochrane Library, Web of Science, Wanfang Data, and China National Knowledge Infrastructure (CNKI) from the date of inception to February 2020, and a meta-analysis was conducted. The primary outcomes of pain intensity (visual analogue scale or numerical rating scale) and knee function [the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)] were evaluated from baseline to various follow-up times by random-effects model. Heterogeneity was assessed by statistic and the potential sources of heterogeneity by subgroup and metaregression analyses, respectively.
Eight publications with 256 patients were included in the meta-analysis. RF could relieve pain with -4.196 of pooled mean difference and improve knee function by decreasing 23.155 points in WOMAC. Three patients had ecchymosis, two with hypoesthesia and one with numbness after the procedure, and improved within 6 months. Furthermore, study design and treatment target were the sources of heterogeneity by subgroup and metaregression analyses, accounting for 37% and 74% of variances, respectively. Target of genicular nerve achieved better pain relief than intra-articular or sciatic nerve. Sensitivity analysis showed that removal of any single study was unlikely to overturn the findings. . There were some limitations in the study. Firstly, the small number of relevant studies limited the confidence level of the meta-analysis. Also, the significant heterogeneity may not be explained due to the limited data. Secondly, the direct comparison of two different guidance methods (ultrasound vs. fluoroscopy) for RF therapy is lacking. In addition, the outcomes were blindly assessed in the meta-analysis from all studies according to evaluation of bias, which could affect the reality of the data. Finally, most of the studies only provided short follow-up times, so we could not analyze the long-term effectiveness of ultrasound-guided RF in the treatment of patients with KOA.
Ultrasonography is an effective, safe, nonradiative, and easily applicable guidance method for RF in pain relief and functional improvement in KOA patients.
膝骨关节炎(KOA)是一种常见的退行性疾病,与关节功能障碍和疼痛有关。超声引导下射频(RF)可能是治疗 KOA 患者慢性疼痛的一种有前途的疗法。
评估超声引导 RF 治疗 KOA 患者慢性疼痛的疗效和安全性。
系统评价,必要时进行荟萃分析。我们评估了评估超声引导 RF 治疗 KOA 人群慢性疼痛的临床疗效的研究。
对从成立到 2020 年 2 月期间在 PubMed、EMBASE、Cochrane 图书馆、Web of Science、万方数据和中国知网(CNKI)中进行的超声引导 RF 治疗 KOA 患者疼痛管理的疗效和安全性进行系统评价,并进行荟萃分析。主要结局指标为疼痛强度(视觉模拟评分或数字评分量表)和膝关节功能[西安大略和麦克马斯特大学骨关节炎指数(WOMAC)],通过随机效应模型从基线到各种随访时间进行评估。通过 Q 统计量评估异质性,并通过亚组分析和荟萃回归分析分别评估潜在的异质性来源。
荟萃分析纳入了 8 项研究共 256 名患者。RF 治疗可减轻疼痛,平均差值为-4.196,通过降低 WOMAC 中的 23.155 点来改善膝关节功能。3 名患者在手术后出现瘀斑,2 名出现感觉迟钝,1 名出现麻木,6 个月内均有所改善。此外,亚组和荟萃回归分析表明,研究设计和治疗靶点是异质性的来源,分别占方差的 37%和 74%。关节内神经和坐骨神经靶点比神经内神经靶点的疼痛缓解效果更好。敏感性分析表明,去除任何单个研究都不太可能推翻研究结果。但是研究存在一些局限性。首先,相关研究数量较少,限制了荟萃分析的置信水平。此外,由于数据有限,显著的异质性可能无法解释。其次,缺乏对 RF 治疗两种不同引导方法(超声与透视)的直接比较。此外,根据偏倚评估,荟萃分析中所有研究的结果都是盲法评估的,这可能会影响数据的真实性。最后,大多数研究仅提供了短期随访时间,因此我们无法分析超声引导 RF 治疗 KOA 患者的长期疗效。
超声是一种有效、安全、非放射性、易于应用的 RF 引导方法,可减轻 KOA 患者的疼痛并改善其功能。